News

Coronavirus

Kimberly Redmond | Equities.com |

After being granted emergency use authorization by the US Food and Drug Administration on Saturday, nearly 4 million doses of Johnson & Johnson’s COVID-19 vaccine are being shipped out across the country. 

During a White House COVID-19 press briefing Monday morning, officials said a rapid rollout of the vaccine stockpile is underway, and Americans ages 18 and older should be able to start getting the single-dose shot within the next 24 to 48 hours. By the end of...


AP News | Equities.com |

In an industrial neighborhood on the outskirts of Bangladesh’s largest city lies a factory with gleaming new equipment imported from Germany, its immaculate hallways lined with hermetically sealed rooms. It is operating at just a quarter of its capacity.

It is one of three factories that The Associated Press found on three continents whose owners say they could start producing hundreds of millions of COVID-19 vaccines on short notice if only they had the blueprints and technical know-how. But that knowledge belongs to the large pharmaceutical companies who have produced the first three vaccines authorized by countries including Britain, the European Union and the U.S. — Pfizer, Moderna and AstraZeneca. The factories are all still awaiting responses.


Reuters | Equities.com |

The head of the U.S. Centers for Disease Control and Prevention said on Friday that a recent decline in COVID-19 cases may be stalling, a development she described as concerning while urging that restrictions to fight the virus remain in place.

Dr. Rochelle Walensky told reporters the CDC was watching the concerning data closely.

The White House on Friday also urged companies to join efforts to help fight the pandemic by requiring mask wearing by employees and educating customers.


Reuters | Equities.com |

The first big real-world study of the Pfizer/BioNTech vaccine to be independently reviewed shows the shot is highly effective at preventing COVID-19, in a potentially landmark moment for countries desperate to end lockdowns and reopen economies.

Up until now, most data on the efficacy of COVID-19 vaccines has come under controlled conditions in clinical trials, leaving an element of uncertainty over how results would translate into the real world with its unpredictable variables.


AP News | Equities.com |

Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J's shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.


Reuters | Equities.com |

Top U.S. infectious disease official Anthony Fauci on Tuesday told CNN that he expects the U.S. Centers for Disease Control and Prevention to soon relax some COVID-19 recommendations aimed at curbing its spread for people who have been vaccinated.


Kimberly Redmond | Equities.com |

British Prime Minister Boris Johnson unveiled what he described as England’s “journey back towards normality,” which calls for the lifting of most major COVID-19-related restrictions in June as long as certain conditions are met.

After imposing the strictest lockdown in the western world in January to curb the spread of a more highly contagious strain of the virus, British pubs, restaurants and non-essential shops are closed, schools and offices are off-limits, gatherings are prohibited and foreign vacations are illegal.


AP News | Equities.com |

The U.S. stood Sunday at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus.

A year into the pandemic, the running total of lives lost was about 498,000 — roughly the population of Kansas City, Missouri, and just shy of the size of Atlanta. The figure compiled by Johns Hopkins University surpasses the number of people who died in 2019 of chronic lower respiratory diseases, stroke, Alzheimer’s, flu and pneumonia combined.


Kimberly Redmond | Equities.com |

The UK will become the first country in the world to deliberately infect healthy volunteers with COVID-19 in what is known as a “human challenge study.”

On Wednesday, the country’s Department for Business, Energy and Industrial Strategy (BEIS) said the $47 million government-funded trial received ethics approval and should begin within the next month.


Reuters | Equities.com |

The White House said on Tuesday it is increasing the supply of coronavirus vaccines sent each week to states to 13.5 million doses, and is also doubling the amount shipped to pharmacies to 2 million doses this week.

White House Press Secretary Jen Psaki said the boost in distribution to states marked a 57% increase since President Joe Biden was inaugurated on Jan. 20.